Loading
A phase 2/3 trial in lung cancer, run by Chang Gung Memorial Hospital, now recruiting.
Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer is a phase 2/3, randomised interventional study registered as NCT02448992 by Chang Gung Memorial Hospital, with a registry enrolment figure of 90 participants, started 2015-08-01 and due to reach its primary completion in 2026-12-31. Interventions recorded: hippocampal-sparing WBRT. Conditions listed: Non-Small-Cell Lung Cancer (NSCLC); Brain Metastasis. Primary outcome: time to the development of brain metastasis/metastases (BM), irrespective of the absence of active neurological symptoms. Lung eligibility wording from the registry: "* Clinical diagnosis of NSCLC". Sites: Taiwan. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.